{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:54:56Z","timestamp":1777121696219,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00660"],"award-info":[{"award-number":["PI17\/00660"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00405"],"award-info":[{"award-number":["PI14\/00405"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12185-019-02796-7","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T11:02:21Z","timestamp":1576926141000},"page":"440-450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular analysis of the novel L243R mutation in STXBP2 reveals impairment of degranulation activity"],"prefix":"10.1007","volume":"111","author":[{"given":"Laura","family":"Vi\u00f1as-Gim\u00e9nez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Donadeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Alsina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena \u00c1lvarez","family":"de la Campa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Esteve-Sole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Catal\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Colobran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"de la Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Say\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7340-2161","authenticated-orcid":false,"given":"M\u00f3nica","family":"Mart\u00ednez-Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,21]]},"reference":[{"key":"2796_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","volume":"14","author":"GE Janka","year":"2014","unstructured":"Janka GE, Lehmberg K. Hemophagocytic syndromes\u2014an update. Blood Rev. 2014;14:135\u201342.","journal-title":"Blood Rev"},{"key":"2796_CR2","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/tra.12337","volume":"16","author":"NMG Dieckmann","year":"2015","unstructured":"Dieckmann NMG, Hackmann Y, Aric\u00f2 M, Griffiths GM. Munc18-2 is required for Syntaxin 11 localization on the plasma membrane in cytotoxic T-lymphocytes. Traffic. 2015;16:1330\u201341.","journal-title":"Traffic."},{"key":"2796_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/jmg.2009.075341","volume":"47","author":"V Cetica","year":"2010","unstructured":"Cetica V, Santoro A, Gilmour KC, Sieni E, Beutel K, Pende D, et al. STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5. J Med Genet. 2010;47:595\u2013600. https:\/\/doi.org\/10.1136\/jmg.2009.075341.","journal-title":"J Med Genet"},{"key":"2796_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","volume":"85","author":"U Stadt","year":"2009","unstructured":"Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85:482\u201392.","journal-title":"Am J Hum Genet"},{"key":"2796_CR5","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1172\/JCI40732","volume":"119","author":"M C\u00f4te","year":"2009","unstructured":"C\u00f4te M, M\u00e9nager MM, Burgess A, Mahlaoui N, Picard C, Schaffner C, et al. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest. 2009;119:3765\u201373.","journal-title":"J Clin Invest."},{"key":"2796_CR6","doi-asserted-by":"publisher","first-page":"E4482","DOI":"10.1073\/pnas.1313474110","volume":"110","author":"Y Hackmann","year":"2013","unstructured":"Hackmann Y, Graham SC, Ehl S, Honing S, Lehmberg K, Arico M, et al. Syntaxin binding mechanism and disease-causing mutations in Munc18-2. Proc Natl Acad Sci. 2013;110:E4482\u201391.","journal-title":"Proc Natl Acad Sci"},{"key":"2796_CR7","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/pbc.24475","volume":"60","author":"P Stepensky","year":"2013","unstructured":"Stepensky P, Bartram J, Barth TF, Lehmberg K, Walther P, Amann K, et al. Persistent defective membrane trafficking in epithelial cells of patients with familial hemophagocytic lymphohistiocytosis type 5 due to STXBP2\/MUNC18-2 mutations. Pediatr Blood Cancer. 2013;60:1215\u201322.","journal-title":"Pediatr Blood Cancer"},{"key":"2796_CR8","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1182\/blood-2010-05-282541","volume":"116","author":"M Meeths","year":"2010","unstructured":"Meeths M, Entesarian M, Al-Herz W, Chiang SCC, Wood SM, Al-Ateeqi W, et al. Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2. Blood. 2010;116:2635\u201343. https:\/\/doi.org\/10.1182\/blood-2010-05-282541.","journal-title":"Blood"},{"key":"2796_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/0003489418771714","volume":"127","author":"A Bezdjian","year":"2018","unstructured":"Bezdjian A, Bruijnzeel H, Pagel J, Daniel SJT, Thomeer HG. Low-frequency sensorineural hearing loss in familial hemophagocytic lymphohistiocytosis type 5. Ann Otol Rhinol Laryngol. 2018;127:409\u201313.","journal-title":"Ann Otol Rhinol Laryngol."},{"issue":"1","key":"2796_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10875-014-0119-z","volume":"35","author":"H Esmaeilzadeh","year":"2015","unstructured":"Esmaeilzadeh H, Bemanian MH, Nabavi M, Arshi S, Fallahpour M, Fuchs I, et al. Novel patient with late-onset familial hemophagocytic lymphohistiocytosis with STXBP2 mutations presenting with autoimmune hepatitis, neurological manifestations and infections associated with hypogammaglobulinemia. J Clin Immunol. 2015;35(1):22\u20135.","journal-title":"J Clin Immunol"},{"key":"2796_CR11","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1182\/blood-2007-02-074468","volume":"110","author":"YT Bryceson","year":"2007","unstructured":"Bryceson YT, Rudd E, Zheng C, Edner J, Ma D, Wood SM, et al. Defective cytotoxic lymphocyte degranulation in syntaxin-11-deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood. 2007;110:1906\u201315.","journal-title":"Blood"},{"key":"2796_CR12","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1182\/blood-2011-07-369090","volume":"118","author":"M Meeths","year":"2011","unstructured":"Meeths M, Chiang SCC, Wood SM, Entesarian M, Schlums H, Bang B, et al. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood. 2011;118:5783\u201393.","journal-title":"Blood"},{"issue":"5","key":"2796_CR13","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.4049\/jimmunol.177.5.2819","volume":"177","author":"A Mart\u00ednez-Barriocanal","year":"2006","unstructured":"Mart\u00ednez-Barriocanal A, Say\u00f3s J. Molecular and functional characterization of CD300b, a new activating immunoglobulin receptor able to transduce signals through two different pathways. J Immunol. 2006;177(5):2819\u201330.","journal-title":"J Immunol."},{"key":"2796_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"2796_CR15","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"N-L Sim","year":"2012","unstructured":"Sim N-L, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40:W452\u20137.","journal-title":"Nucleic Acids Res"},{"key":"2796_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/nar\/gki387","volume":"33","author":"J Schymkowitz","year":"2005","unstructured":"Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web server: an online force field. Nucleic Acids Res. 2005;33:382.","journal-title":"Nucleic Acids Res."},{"key":"2796_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-cellbio-111315-125334","volume":"33","author":"E Pilla","year":"2017","unstructured":"Pilla E, Schneider K, Bertolotti A. Coping with protein quality control failure. Annu Rev Cell Dev Biol. 2017;33:439\u201365.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2796_CR18","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1182\/blood-2011-12-398958","volume":"119","author":"J Pagel","year":"2012","unstructured":"Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs A-K, et al. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood. 2012;119:6016\u201324. https:\/\/doi.org\/10.1182\/blood-2011-12-398958.","journal-title":"Blood"},{"issue":"1","key":"2796_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1182\/blood-2013-03-494039","volume":"122","author":"XW Zhao","year":"2013","unstructured":"Zhao XW, Gazendam RP, Drewniak A, Van Houdt M, Tool ATJ, Van Hamme JL, et al. Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2\/Munc18-2 mutations. Blood. 2013;122(1):109\u201311.","journal-title":"Blood"},{"issue":"12","key":"2796_CR20","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3324\/haematol.2010.029389","volume":"95","author":"J Rohr","year":"2010","unstructured":"Rohr J, Beutel K, Maul-Pavicic A, Vraetz T, Thiel J, Warnatz K, et al. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica. 2010;95(12):2080\u20137.","journal-title":"Haematologica"},{"key":"2796_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fimmu.2018.00529","volume":"9","author":"JA Lopez","year":"2018","unstructured":"Lopez JA, Noori T, Minson A, Jovanoska LL, Thia K, Hildebrand MS, et al. Bi-allelic mutations in STXBP2 reveal a complementary role for STXBP1 in cytotoxic lymphocyte killing. Front Immunol. 2018;9:529.","journal-title":"Front Immunol."},{"issue":"2","key":"2796_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/cge.12682","volume":"89","author":"JY Seo","year":"2016","unstructured":"Seo JY, Lee KO, Yoo KH, Sung KW, Koo HH, Kim SH, et al. Prevalence of type 5 familial hemophagocytic lymphohistiocytosis in Korea and novel mutations in STXBP2. Clin Genet. 2016;89(2):222\u20137.","journal-title":"Clin Genet."},{"issue":"12","key":"2796_CR23","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1182\/blood-2012-05-430629","volume":"120","author":"R Al Hawas","year":"2012","unstructured":"Al Hawas R, Ren Q, Ye S, Karim ZA, Filipovich AH, Whiteheart SW. Munc18b\/STXBP2 is required for platelet secretion. Blood. 2012;120(12):2493\u2013500.","journal-title":"Blood."},{"issue":"9","key":"2796_CR24","doi-asserted-by":"publisher","first-page":"e44649","DOI":"10.1371\/journal.pone.0044649","volume":"7","author":"E Sieni","year":"2012","unstructured":"Sieni E, Cetica V, Piccin A, Gherlinzoni F, Sasso FC, Rabusin M, et al. Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series. PLoS One. 2012;7(9):e44649.","journal-title":"PLoS One."},{"key":"2796_CR25","doi-asserted-by":"publisher","first-page":"e26264","DOI":"10.1002\/pbc.26264","volume":"64","author":"X-J Xu","year":"2017","unstructured":"Xu X-J, Wang H-S, Ju X-L, Xiao P-F, Xiao Y, Xue H-M, et al. Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: a retrospective multicenter study [Internet]. Pediatr Blood Cancer. 2017;64:e26264.","journal-title":"Pediatr Blood Cancer."},{"issue":"6","key":"2796_CR26","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.jaci.2011.12.1003","volume":"129","author":"RW Saltzman","year":"2012","unstructured":"Saltzman RW, Monaco-Shawver L, Zhang K, Sullivan KE, Filipovich AH, Orange JS. Novel mutation in STXBP2 prevents IL-2-induced natural killer cell cytotoxicity. J Allergy Clin Immunol. 2012;129(6):1666\u20138.","journal-title":"J Allergy Clin Immunol."},{"issue":"6","key":"2796_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s13312-012-0094-5","volume":"49","author":"R Jain","year":"2012","unstructured":"Jain R, Puliyel M, Moses PD, Sieni E. Novel STXBP2 mutation causing familial hemophagocytic lymphohistiocytosis. Indian Pediatr. 2012;49(6):488\u201390.","journal-title":"Indian Pediatr."},{"issue":"4","key":"2796_CR28","first-page":"280","volume":"50","author":"CR Tong","year":"2011","unstructured":"Tong CR, Liu HX, Xie JJ, Wang F, Cai P, Wang H, et al. The study of gene mutations in unknown refractory viral infection and primary hemophagocytic lymphohistiocytosis. Zhonghua Nei Ke Za Zhi. 2011;50(4):280\u20133.","journal-title":"Zhonghua Nei Ke Za Zhi."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02796-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02796-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02796-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,20]],"date-time":"2020-12-20T00:34:29Z","timestamp":1608424469000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02796-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,21]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["2796"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02796-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,21]]},"assertion":[{"value":"25 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}